Login to your account

Username *
Password *
Remember Me

Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination – JAMA  

The post Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7 appeared first on Links Medicus.

Expert consensus statements for the management of COVID-19-related acute respiratory failure

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method – Critical Care   Commentary on Twitter ?Expert consensus statements for the management of ?? COVID-19-related acute respiratory failure using a Delphi method.?????https://t.co/ujt8669VAb pic.twitter.com/AlT0ZkdKSc — RECAT??‍⚕️???‍⚕️ (@LeslieMegom) March 17, 2021  

The post Expert consensus statements for the management of COVID-19-related acute respiratory failure appeared first on Links Medicus.

Perspective | Five reasons why COVID herd immunity is probably impossible

Five reasons why COVID herd immunity is probably impossible – Nature  

The post Perspective | Five reasons why COVID herd immunity is probably impossible appeared first on Links Medicus.

Leprosy drug holds promise as at-home treatment for COVID-19

Leprosy drug holds promise as at-home treatment for COVID-19 – Sanford Burnham Prebys Medical Discovery Institute Original article: Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 – Nature  

The post Leprosy drug holds promise as at-home treatment for COVID-19 appeared first on Links Medicus.

CDC: SARS-CoV-2 Variants of Concern

SARS-CoV-2 Variants – Centers for Disease Control and Prevention Commentaries: Coronavirus strains first detected in California are officially ‘variants of concern,’ CDC says – CNN AND CDC IDs new COVID-19 variants of concern as hot spots reemerge – CIDRAP  

The post CDC: SARS-CoV-2 Variants of Concern appeared first on Links Medicus.

SARS-CoV-2 transmission without symptoms

SARS-CoV-2 transmission without symptoms – Science (a few articles per month are free)  

The post SARS-CoV-2 transmission without symptoms appeared first on Links Medicus.

How do you treat coronavirus? Here are physicians’ best strategies

How do you treat coronavirus? Here are physicians’ best strategies – Science (a few articles per month are free)  

The post How do you treat coronavirus? Here are physicians’ best strategies appeared first on Links Medicus.

Current evidence for COVID-19 therapies: a systematic literature review

Current evidence for COVID-19 therapies: a systematic literature review – European Respiratory Review  

The post Current evidence for COVID-19 therapies: a systematic literature review appeared first on Links Medicus.

European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets – European Medicines Agency Commentaries: Restoring confidence after the covid-19 Oxford/AstraZeneca vaccine pause will be an uphill battle – The BMJ Opinion AND European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible […]

The post European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks appeared first on Links Medicus.

RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial – JAMA Editorial: Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 – JAMA   Commentary on Twitter Intermediate-dose prophylactic enoxaparin (1 mg/kg/d) had […]

The post RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit appeared first on Links Medicus.

Recherche